Insights

Manufacturing Partnerships Emergent has active expansion and manufacturing collaborations, including Canton, Ohio expansion and partnerships with SAB Biotherapeutics and Substipharm SrL to develop and manufacture vaccines and biologics. This creates sales opportunities for contract development and manufacturing, process development support, supply chain optimization, and regulatory services for biotech programs.

Public Health Distribution The company engages in naloxone distribution through Take-Home Naloxone programs and government partnerships, indicating a channel for public-health product distribution, logistics, cold-chain, and pharmacy partnerships that could be explored for new product rollouts or expanded access programs.

Government Procurement With government partnerships in Canada and a SAP Ariba-based procurement workflow, Emergent is positioned to win public-sector contracts and requires compliant procurement, supplier onboarding, and integrated supply chain solutions that could be offered as services.

Tech Driven Operations A mature tech stack including Oracle Cloud, SAP Ariba, and other enterprise tools signals readiness for IT modernization, data analytics, cybersecurity, and ERP optimization services to support manufacturing, testing, and distribution operations.

Scale Growth The company operates at a sizable scale with ongoing funding, implying capacity for long-term, multi-year collaborations across vaccine development, manufacturing, testing services, and public-health product distribution, presenting cross-sell opportunities for CRO/CMO services, testing platforms, and logistics solutions.

Emergent BioSolutions Tech Stack

Emergent BioSolutions uses 8 technology products and services including Oracle Cloud, Microsoft Active Directory, jQuery, and more. Explore Emergent BioSolutions's tech stack below.

  • Oracle Cloud
    Data Management Platforms
  • Microsoft Active Directory
    Identity And Access Management
  • jQuery
    Javascript Libraries
  • Splunk
    Miscellaneous
  • Cisco
    Network Hardware
  • Windows Server
    Operating Systems
  • Pantheon
    Platform As A Service
  • Ariba Sourcing
    Procurement

Media & News

Emergent BioSolutions's Email Address Formats

Emergent BioSolutions uses at least 3 format(s):
Emergent BioSolutions Email FormatsExamplePercentage
LastF@ebsi.comDoeJ@ebsi.com
87%
FLast@ebsi.comJDoe@ebsi.com
8%
FirstL@ebsi.comJohnD@ebsi.com
3%
Last@ebsi.comDoe@ebsi.com
2%
First.Last@emergentbiosolutions.comJohn.Doe@emergentbiosolutions.com
75%
LastF@emergentbiosolutions.comDoeJ@emergentbiosolutions.com
11%
First_Last@emergentbiosolutions.comJohn_Doe@emergentbiosolutions.com
10%
First.L@emergentbiosolutions.comJohn.D@emergentbiosolutions.com
4%
FLast@paxvax.comJDoe@paxvax.com
83%
Last@paxvax.comDoe@paxvax.com
10%
FirstLast@paxvax.comJohnDoe@paxvax.com
4%
FirLast@paxvax.comJohDoe@paxvax.com
3%

Frequently Asked Questions

What is Emergent BioSolutions's phone number?

Minus sign iconPlus sign icon
You can contact Emergent BioSolutions's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Emergent BioSolutions's stock symbol?

Minus sign iconPlus sign icon
Emergent BioSolutions is a publicly traded company; the company's stock symbol is EBS.

What is Emergent BioSolutions's official website and social media links?

Minus sign iconPlus sign icon
Emergent BioSolutions's official website is emergentbiosolutions.com and has social profiles on LinkedInCrunchbase.

How much revenue does Emergent BioSolutions generate?

Minus sign iconPlus sign icon
As of July 2026, Emergent BioSolutions's annual revenue is estimated to be $1B.

What is Emergent BioSolutions's SIC code NAICS code?

Minus sign iconPlus sign icon
Emergent BioSolutions's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Emergent BioSolutions have currently?

Minus sign iconPlus sign icon
As of July 2026, Emergent BioSolutions has approximately 1.4K employees across 6 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer President: K. S.Chief Medical Officer, Head Of Clinical Development: C. C.Chief Scientific Officer: W. J.. Explore Emergent BioSolutions's employee directory with LeadIQ.

What industry does Emergent BioSolutions belong to?

Minus sign iconPlus sign icon
Emergent BioSolutions operates in the Biotechnology Research industry.

What technology does Emergent BioSolutions use?

Minus sign iconPlus sign icon
Emergent BioSolutions's tech stack includes Oracle CloudMicrosoft Active DirectoryjQuerySplunkCiscoWindows ServerPantheonAriba Sourcing.

What is Emergent BioSolutions's email format?

Minus sign iconPlus sign icon
Emergent BioSolutions's email format typically follows the pattern of LastF@ebsi.com. Find more Emergent BioSolutions email formats with LeadIQ.

How much funding has Emergent BioSolutions raised to date?

Minus sign iconPlus sign icon
As of July 2026, Emergent BioSolutions has raised $287M in funding. The last funding round occurred on Aug 30, 2024 for $250M.

When was Emergent BioSolutions founded?

Minus sign iconPlus sign icon
Emergent BioSolutions was founded in 1998.
Emergent BioSolutions logo

Emergent BioSolutions

Biotechnology ResearchMaryland, United States1001-5000 Employees

Emergent BioSolutions is a biotechnology research company focused on developing, manufacturing, and delivering protections against public health threats. Based in Gaithersburg, Maryland, the firm has been in operation for more than twenty years, working to prepare for health emergencies rather than merely reacting to them. Its activities encompass creating products and solutions intended to shield people from potential health threats and to support public health preparedness. 

The company serves government and public health customers, collaborating with health authorities to provide protective products and related manufacturing capabilities. In a recent development, Emergent entered a multi-year agreement with SAB Biotherapeutics to support the process development and manufacturing of SAB-142, the lead program in clinical development for autoimmune type 1 diabetes.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
EBS
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1998
Employees
1001-5000

Section iconFunding & Financials

  • $287M

    Emergent BioSolutions has raised a total of $287M of funding over 5 rounds. Their latest funding round was raised on Aug 30, 2024 in the amount of $250Mas a post_ipo_debt.

  • $500M$1B

    Emergent BioSolutions's revenue is estimated to be in the range of $500M$1B

Section iconFunding & Financials

  • $287M

    Emergent BioSolutions has raised a total of $287M of funding over 5 rounds. Their latest funding round was raised on Aug 30, 2024 in the amount of $250Mas a post_ipo_debt.

  • $500M$1B

    Emergent BioSolutions's revenue is estimated to be in the range of $500M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.